News for Meridian Bioscience, Inc. (VIVO)

Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031)....

Integration of Real-Time Polymerase Chain Reaction Technology Pushing Use of Rapid Medical Diagnostic Kits...

Discover the booming blood screening market from 2024 to 2031, as innovative technologies and rising health awareness drive demand across diverse product...

BETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and...

The Global GI Stool Testing Market Size was Valued at USD 580.0 Million in 2023 and the Worldwide GI Stool Testing Market Size is Expected to Reach USD...

The Global Fecal Calprotectin Test Market Size was Valued at USD 126.15 Million in 2023 and the Worldwide Fecal Calprotectin Test Market Size is Expected...

Investments Increasing to Improve Design, Durability, and Quality of Rapid Influenza Diagnostic Test Kits...

The norovirus diagnostics market was valued at USD 65.5 Billion in 2023 and is expected to reach USD 130.4 Billion by 2032 at a CAGR of 7.9%....

Increasing need for rapid test results and point of care diagnostic...

The global influenza diagnostics market size and share are currently valued at USD 0.79 billion in 2023. It is anticipated to generate an estimated revenue...

Intense competition among key players drives innovation and product differentiation in the helicobacter pylori non-invasive testing market....

Blood screening market is segmented on the basis of product type, end users. By product type, the market is segmented into reagents & kits, instruments,...

The Influenza Diagnostics Market is poised for substantial growth, driven by increasing awareness, advancements in diagnostic technologies, and the...

The global point-of-care molecular diagnostics market is growing at a CAGR of 13.4% from 2021 to 2028....

SkyQuest projects that the rapid diagnostics market will attain a value of USD 16.93 billion by 2030, with a CAGR of 2.3% over the forecast period...

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board...

SkyQuest projects that the influenza diagnostics market will attain a USD 1.46 billion value by 2030, with a CAGR of 3.5% over the forecast period...

/PRNewswire/ --The "Global Sequencing Reagents Market by Technology, Type, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...

/PRNewswire/ -- The point-of-care diagnostics market size is estimated to grow by USD 14,645.04 million between 2022 and 2027, accelerating at a CAGR of 10.65%...